---
title: "Bristol-Myers Squibb Company (CELG.RT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CELG.RT.US.md"
symbol: "CELG.RT.US"
name: "Bristol-Myers Squibb Company"
industry: "Oncology Biopharmaceuticals"
---

# Bristol-Myers Squibb Company (CELG.RT.US)

| Item | Detail |
|------|--------|
| Industry | Oncology Biopharmaceuticals |
| Location | US Market |
| Website | [www.bms.com](https://www.bms.com) |

## Company Profile

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Opdivo for various an...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CELG.RT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CELG.RT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CELG.RT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.